[1]冷 静,王艳梅,李 慧△.理肺化瘀方治疗支气管哮喘疗效及对患者血清内IgG、IgA、IgM的变化研究*[J].陕西中医,2020,(5):618-620.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
　LENG Jing,WANG YanMei,LI Hui..Lifei Huayu decoction in the treatment of bronchial asthma and the change of serum IgG,IgA,IgM in patients[J].,2020,(5):618-620.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
点击复制

理肺化瘀方治疗支气管哮喘疗效及对患者血清内IgG、IgA、IgM的变化研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年5期
页码:
618-620
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Lifei Huayu decoction in the treatment of bronchial asthma and the change of serum IgG,IgA,IgM in patients
作者:
冷 静; 王艳梅; 李 慧△
新疆医科大学第二附属医院(乌鲁木齐 830000)
Author(s):
LENG Jing; WANG YanMei; LI Hui.
The Second Affiliated Hospital of Xinjiang Medical University(Urumqi 830000)
关键词:
支气管哮喘;  理肺化瘀方;  免疫功能;  白三烯D4;  高迁移率族蛋白1;  嗜酸性粒细胞
Keywords:
Bronchial asthma;  Lifei Huayu decoction;  Immune function;  LTD4;  HMGBI;  EOS
分类号:
R562.25
DOI:
DOI:10.3969/j.issn.10007369.2020.05.018
文献标志码:
A
摘要:
目的:分析理肺化瘀方对支气管哮喘患者的疗效及患者血清内免疫球蛋白G、免疫球蛋白A、免疫球蛋白M的变化。方法:选取支气管哮喘患者302例,根据治疗方法不同分为两组,每组151例。对照组给予常规治疗,观察组在对照组基础上给予自拟理肺化瘀方剂治疗,分析两组患者治疗后的临床疗效。结果:治疗后,观察组喘息、哮鸣音积分及嗜酸性粒细胞(EOS)、白三烯D4(LTD4)、高迁移率族蛋白1(HMGB1)、二氧化碳分压(PaCO2)、免疫球蛋白E(lgE)水平低于对照组,环磷酸腺苷(cAMP)、酸碱度(pH)、氧分压(PaO2)、IgG、IgA、IgM水平高于对照组(P<0.05)。结论:自拟理肺化瘀方剂治疗支气管哮喘,可改善患者临床症状、血气指标及免疫功能。
Abstract:
Objective:To analyze the effect of Lifei Huayu decoction on patients with bronchial asthma and the changes of serum immunoglobulin G(IgG),immunoglobulin A(IgA)and immunoglobulin M(IgM)in patients.Methods:Selected 302 patients with bronchial asthma,divided into 2 groups according to the treatment methods,151 in each group.The control group was given routine treatment,and the observation group was given Liqi Huayu decoction on the basis of the control group to analyze the clinical effect of the two groups of patients after treatment.Results:After treatment,asthma,wheezing scores and eosinophils(EOS),leukotriene D4(LTD4),high mobility group protein 1(HMGB1),partial pressure of carbon dioxide(PaCO2),immunoglobulin E.The levels of cyclic adenosine monophosphate(cAMP),acidity and alkalinity(pH),oxygen pressure(PaO2),IgG,IgA,IgM were higher than those of control group(P<0.05).Conclusion:To treat bronchial asthma with Lifei Huayu decoction can improve the clinical symptom,blood gas index and immune function.

参考文献/References:

[1] 牟京辉,邵明军,刘传合,等.中国城市支气管哮喘儿童与非支气管哮喘儿童食物过敏患病情况比较[J].中华实用儿科临床杂志,2018,33(9):684-687.
[2] 吕昊泽,刘仲祥,侯松萍,等.布地奈德、沙丁胺醇联合噻托溴铵治疗老年支气管哮喘效果分析[J].中国老年学杂志,2016,36(16):4001-4002.
[3] 钟远芹,蓝伟峰.布地奈德联合沙丁胺醇治疗支气管哮喘的效果及对患者TGF-β1、CRP水平和肺功能的影响[J].广东医学,2016,37(6):915-917.
[4] 和春芳.通肺平喘汤联合布地奈德对老年支气管哮喘患者外周血Th17/Treg表达的影响[J].中国老年学杂志,2016,36(21):5371-5373.
[5] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2016年版)[J].中华结核和呼吸杂志,2016,39(9):675-697.
[6] 国家食品药品监督管理总局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:112.
[7] Baptist AP,Busse PJ.Asthma over the age of 65:all's well that ends well[J].Journal of Allergy & Clinical Immunology in Practice,2018,6(3):764-773.
[8] 李红霞.布地奈德与特布他林联合雾化吸入治疗儿童支气管哮喘急性发作的疗效观察[J].中国医院用药评价与分析,2016,16(4):451-453.
[9] 蒋 昱,张才擎.溴化异丙托品联合布地奈德/福莫特罗粉吸入剂对支气管哮喘患者血清IgE、FeNO及肺功能的影响[J].中国生化药物杂志,2016,36(6):91-93.
[10] 庄慧光,王秀川,梁瑞琼,等.布地奈德福莫特罗粉吸入剂治疗中重度支气管哮喘疗效分析[J].海南医学,2016,27(4):621-623.
[11] 陈青青.沙丁胺醇与布地奈德联合治疗支气管哮喘的临床疗效[J].中国生化药物杂志,2017,37(2):267-269.
[12] 王至婉,李建生,余学庆,等.支气管哮喘不同时期证候演变规律的临床调查研究[J].北京中医药大学学报,2016,5(2):136-139.
[13] 杨宏彬,黄鑫华,吴文斌.自拟理肺化瘀方治疗支气管哮喘的疗效观察[J].中医临床研究,2017,9(25):64-65.
[14] 黄 南,王晓龙,李文静,等.泻痰清肺方对支气管哮喘患者血清TNF-α和IL-8水平的影响[J].陕西中医,2017,38(5):588-589.
[15] 高 雅,田 丽,李 芳,等.基于益气固本、理肺祛邪法论治小儿支气管哮喘缓解期[J].中医杂志,2016,57(16):1428-1429.
[16] 徐则林,李晓屏,王顺民,等.补肺益肾膏治疗支气管哮喘非急性发作期的临床疗效观察[J].湖南中医药大学学报,2016,36(1):70-73.

相似文献/References:

[1]吕明辉,贾艳平,元国红.清热涤痰定喘汤联合穴位贴敷治疗儿童支气管哮喘安全性及疗效分析[J].陕西中医,2019,(1):25.
　LV Minghui,JIA Yanping,YUAN Guohong..Safety and efficacy of Qingre Ditan Dingchuan decoction combined with acupoint sticking in the treatment of bronchial asthma in children[J].,2019,(5):25.
[2]李红芬,毕玲莉,张茂华.小青龙汤联合糖皮质激素对支气管哮喘患儿气道重塑 及相关炎症因子的影响[J].陕西中医,2019,(5):631.
　LI Hongfen,BI Lingli,ZHANG Maohua..Effects of Xiaoqinglong decoction combined with glucocorticoid on airway remodeling and related inflammatory factors in children with bronchial asthma[J].,2019,(5):631.
[3]唐徐韵,陈盼碧△.穴位埋线治疗支气管哮喘的实验研究探讨*[J].陕西中医,2019,(12):1789.
[4]王兰香,李卫红,周 瑾,等.消积豁痰汤加减联合糖皮质激素治疗老年支气管哮喘临床研究[J].陕西中医,2021,(6):724.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.011]
[5]何 蕊,程玉峰,李艳彬.射干麻黄汤加减对支气管哮喘疗效及患者炎症反应的影响[J].陕西中医,2021,(9):1211.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.015]
　HE Rui,CHENG Yufeng,LI Yanbin.Effect of modified Shegan Mahuang decoction on bronchial asthma and inflammation[J].,2021,(5):1211.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.015]
[6]高 辉,刘 恭,韩仙菊.黄芩素上调miR-625-5p表达干预支气管哮喘小鼠的机制研究[J].陕西中医,2022,(7):838.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.005]
　GAO Hui,LIU Gong,HAN Xianju.The mechanism of baicalein up-regulating miR-625-5p expression in bronchial asthma mice[J].,2022,(5):838.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.005]
[7]孟玲玉,黄 燕,包海鹏,等.加味过敏煎对支气管哮喘大鼠嗜酸性粒细胞凋亡及Fas、Bcl-2调节作用的研究[J].陕西中医,2023,(5):562.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.004]
　MENG Lingyu,HUANG Yan,BAO Haipeng,et al.Research of Jiawei Guomin decoction on eosinophil apoptosis and the regulation mechanism of Fas,Bcl-2 in bronchial asthma rats[J].,2023,(5):562.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.004]
[8]王 伟,马丽华,鞠 上.投杯汤治疗支气管哮喘疗效及对患者气道重塑和气道炎症的影响[J].陕西中医,2023,(8):1047.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.011]
　WANG Wei,MA Lihua,JU Shang.Effect of Toubei decoction on bronchial asthma and its influence on airway remodeling and inflammation[J].,2023,(5):1047.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.011]
[9]季雅楠,田春燕,郭丹丹,等.基于PI3K/Akt信号通路探讨中医药治疗支气管哮喘研究进展[J].陕西中医,2023,(12):1827.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]
　JI Yanan,TIAN Chunyan,GUO Dandan,et al.Progress in the treatment of bronchial asthma with traditional Chinese medicine based on PI3K/Akt signaling pathway[J].,2023,(5):1827.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]
[10]冉秦杰,黄娇娇,孟 泳.定喘汤通过miR-130a-3p调控TGF-β1通路减轻支气管哮喘大鼠气道重塑机制研究[J].陕西中医,2025,46(4):456.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.005]

备注/Memo

备注/Memo:
*新疆维吾尔自治区自然科学基金资助项目(2018D01C242)
更新日期/Last Update: 2020-05-14